The importance of time to market for New Chemical Entities
In the highly competitive pharmaceutical industry, time to market plays a pivotal role in determining the success of a new drug. For new chemical entities (NCEs), rapid development and commercialization can significantly impact patient care and ensure that life-saving...
Anne-Kathrin Stoller to become new CEO at Bachem
Bachem (SIX: BANB) announced today that its Board of Directors has appointed Anne-Kathrin Stoller, currently Head of Bachem Americas and previously the company’s long-standing Chief Marketing Officer (CMO), as its new CEO, effective January 1, 2026. She succeeds...
Bachem announces progress in Building K start-up and expansion of its site in Vista, CA
The capacity expansion in Bubendorf reached another important milestone with the inspection of Building K. The announced start-up is proceeding according to plan. In Vista, CA, Bachem acquired a property adjacent to its existing facility. The acquisition will enable a...
What is enzymatic ligation and what are the benefits?
Oligonucleotide therapeutics are becoming increasingly complex, pushing traditional manufacturing methods to their limits. As researchers develop longer sequences with sophisticated modifications, a new approach is gaining prominence: enzymatic ligation. This...